EUVIMEDEUVIMED entdecken
Crossref

Association of HBeAg decline rate from mid‐pregnancy to delivery with HBeAg seroconversion after delivery in hepatitis B virus‐infected mothers

Wenting Zhong iD, Jie Zheng, Naijuan Yao, Yali Feng, Yage Zhu, Zhe Jiao, Lanzhi Yan, Lei Shi, Yingli He iD, Tianyan Chen iD

Journal of Viral Hepatitis · 2024

DOI: 10.1111/jvh.13948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Wenting Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Hepatitis B e Antigens, Seroconversion, Pregnancy Complications, Infectious, Postpartum Period. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: the Clinical Research Award of the First Affiliated Hospital of Xian Jiaotong University, China (XJTU1AF-CRF-2020-001), Shaanxi Key Research and Development Program (2021ZDLSF-04-14).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is still controversy about whether to continue antiviral therapy (AVT) after delivery, especially for pregnant women in the immune tolerance (IT) phase. In this study, a retrospective cohort study was conducted to explore the relationship between hepatitis B e antigen (HBeAg) decline rate (%) from mid‐pregnancy to delivery and HBeAg seroconversion postpartum among patients using nucleos(t)ide analogs (NAs) to prevent mother‐to‐child transmission (MTCT), with the goal of identifying the ideal candidates for postpartum AVT continuation. This retrospective cohort study included 151 postpartum women. Univariate and multivariable logistic regression analyses were conducted to assess the association between the HBeAg decline rate (%) from mid‐pregnancy to delivery and HBeAg seroconversion postpartum. Receiver operating characteristic (ROC) analysis was utilized to evaluate the predictive capacity of the HBeAg decline rate (%) and determine the optimal cut‐off point. The univariate analysis revealed a significant association between the HBeAg decline rate (%) and HBeAg seroconversion postpartum (OR 1.068, 95% CI: 1.034–1.103, p < .001). In the multivariate regression analysis, adjusting for age, hepatitis B surface antigen (HBsAg) titre (log10 IU/mL) at mid‐pregnancy, HBeAg titre (log10 S/CO) at mid‐pregnancy, and hepatitis B virus (HBV) DNA load decline rate (%) from mid‐pregnancy to delivery, the HBeAg decline rate(%) remained significantly associated with HBeAg seroconversion postpartum (OR 1.050, 95% CI: 1.015–1.093, p = .009). Then HBeAg decline rate (%) was treated as a categorical variable (tertiles) for sensitivity analysis. In the three distinct models, taking Tertile1 as a reference, women in Tertile3 still had a 4.201‐fold (OR 4.201, 95% CI: 1.382–12.773, p = .011) higher risk of developing HBeAg seroconversion ( p for trend

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B e AntigensSeroconversionPregnancy Complications, InfectiousPostpartum PeriodHumansFemalePregnancyAdultRetrospective StudiesAntiviral AgentsInfectious Disease Transmission, VerticalHepatitis B, ChronicYoung AdultROC CurveHepatitis BHepatitis B virus

Substanzen

Hepatitis B e AntigensAntiviral Agents

Autor:innen und Institutionen

  • Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

ORCID-Profile: Wenting Zhong, Yingli He, Tianyan Chen

Förderung

  • the Clinical Research Award of the First Affiliated Hospital of Xian Jiaotong University, China (XJTU1AF-CRF-2020-001)
  • Shaanxi Key Research and Development Program (2021ZDLSF-04-14)

Zitieren

APA

Zhong, W., Zheng, J., Yao, N., Feng, Y., Zhu, Y., Jiao, Z., Yan, L., Shi, L., He, Y., & Chen, T. (2024). Association of HBeAg decline rate from mid‐pregnancy to delivery with HBeAg seroconversion after delivery in hepatitis B virus‐infected mothers. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13948

Vancouver

Zhong W, Zheng J, Yao N, Feng Y, Zhu Y, Jiao Z, et al. Association of HBeAg decline rate from mid‐pregnancy to delivery with HBeAg seroconversion after delivery in hepatitis B virus‐infected mothers. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13948

BibTeX
@article{Zhong2024,
  author = {Zhong, Wenting and Zheng, Jie and Yao, Naijuan and Feng, Yali and Zhu, Yage and Jiao, Zhe and Yan, Lanzhi and Shi, Lei and He, Yingli and Chen, Tianyan},
  title = {Association of HBeAg decline rate from mid‐pregnancy to delivery with HBeAg seroconversion after delivery in hepatitis B virus‐infected mothers},
  journal = {Journal of Viral Hepatitis},
  year = {2024},
  doi = {10.1111/jvh.13948}
}
Kostenlos starten →